|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000080 USD | +7,900.00% |
|
-.--% | - |
| 3 years | 0 |  | 0 |
| 5 years | 0 | | 0.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CEO | Chief Executive Officer | 60 | - |
| Director of Finance/CFO | 78 | 02/08/2012 | |
Steven Byle
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CHM | Chairman | 60 | 20/01/2010 |
Steven Byle
BRD | Director/Board Member | 58 | 09/11/2009 |
Roger Fidler
BRD | Director/Board Member | 75 | 30/12/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7,900.00% | -.--% | - | - | 0 | |
| +0.49% | +1.90% | +38.82% | +0.31% | 77.1B | |
| +0.13% | +1.26% | +22.33% | +182.41% | 49.43B | |
| +2.77% | +1.90% | -1.84% | +27.14% | 49.27B | |
| -0.13% | +3.33% | -50.97% | -50.14% | 44.59B | |
| -0.51% | +1.11% | +60.62% | -24.35% | 30.48B | |
| +1.63% | +0.36% | +53.39% | +84.79% | 24B | |
| +7.23% | +4.65% | +115.60% | -43.31% | 21.5B | |
| +4.29% | +7.66% | -3.26% | +189.18% | 20.18B | |
| +2.33% | -2.89% | +66.79% | +125.79% | 16.29B | |
| Average | +791.82% | +0.71% | +33.50% | +54.65% | 33.28B | |
| Weighted average by Cap. | +1.46% | +2.58% | +25.15% | +43.17% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PROT Stock
Select your edition
All financial news and data tailored to specific country editions
